Understanding how cancers develop resistance to irreversible EGFR tyrosine kinase inhibitors through the IGF1R pathway and multistep survival strategies.
Explore how pyrazole-based compounds are revolutionizing EGFR-targeted cancer therapy through precise molecular design and innovative treatment approaches.